561 related articles for article (PubMed ID: 30702589)
1. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-associated lymphoid tissue lymphoma with unusual
Zhang NS; Shi F; Kong L; Zhu H
World J Gastroenterol; 2017 Jan; 23(3):551-559. PubMed ID: 28210093
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of baseline
Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era.
Song GY; Yoon SE; Kim SJ; Kim JS; Koh Y; Moon JH; Oh SY; Lee HS; Shin HJ; Do YR; Lee WS; Kim DS; Park Y; Yhim HY; Yang DH
Sci Rep; 2020 Jul; 10(1):11649. PubMed ID: 32669642
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.
Zhao K; Luo YZ; Zhou SH; Dai BL; Luo XM; Yan SX; Wang QY; Ling L
J Int Med Res; 2012; 40(3):1192-206. PubMed ID: 22906294
[TBL] [Abstract][Full Text] [Related]
6. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705
[TBL] [Abstract][Full Text] [Related]
7.
Albano D; Durmo R; Treglia G; Giubbini R; Bertagna F
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):137-146. PubMed ID: 32029397
[TBL] [Abstract][Full Text] [Related]
8. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Yang X; Min X; He W
Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT and primary hepatic MALT: a case series.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
Hoffmann M; Kletter K; Diemling M; Becherer A; Pfeffel F; Petkov V; Chott A; Raderer M
Ann Oncol; 1999 Oct; 10(10):1185-9. PubMed ID: 10586335
[TBL] [Abstract][Full Text] [Related]
11. The use of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography integrated with computed tomography for accurate staging and surveillance in the case of mucosa-associated lymphoid tissue.
Zhang S; Rossetti-Chung A; Sood S; Terezakis S
J Radiol Case Rep; 2021 Mar; 15(3):19-28. PubMed ID: 34267867
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
13. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
[TBL] [Abstract][Full Text] [Related]
14. Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
Albano D; Bosio G; Orlando E; Bertagna F
Hematol Oncol; 2017 Dec; 35(4):884-889. PubMed ID: 28004400
[TBL] [Abstract][Full Text] [Related]
15. Mucosa-associated lymphoid tissue lymphoma of the accessory parotid gland presenting as a simple cheek mass: A case report.
Hwang JH; Kim DW; Kim KS; Lee SY
Medicine (Baltimore); 2019 Sep; 98(36):e17042. PubMed ID: 31490395
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge.
Hsiao YS; Shen SC; Hsiao SC
Am J Case Rep; 2024 Apr; 25():e943275. PubMed ID: 38644602
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature.
Bao C; Wei J; Zhao X; Lin L; Chen D; Liu K; Qian W; Anas JM; Zhao K
Medicine (Baltimore); 2018 Mar; 97(10):e9877. PubMed ID: 29517697
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT Findings of MALT Lymphoma of Ureter.
He L; Deng Y; Deng Y; Xie H; Zhang W
Clin Nucl Med; 2022 Sep; 47(9):828-829. PubMed ID: 35930711
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
Park SH; Lee JJ; Kim HO; Lee DY; Suh C; Jung HY; Choi KD; Kim DH; Huh J; Ryu JS
Leuk Lymphoma; 2015; 56(12):3288-94. PubMed ID: 25804932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
